Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company with a current market capitalization of $16.36 million, has confirmed its compliance with Nasdaq's minimum ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

The field of paleo-inspired robotics is opening up a new way to turn back time and studying prehistoric animals.

While advancements in biotechnology hold immense promise for health and innovation, they also come with significant risks if ...

New methodology reduces the data requirements for protein engineering by 99% so organizations can unlock innovation even in ...

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

PROVIDENCE, RI - Ocean Biomedical (NASDAQ: OCEA) has announced research findings that show its immunotherapy candidates can work synergistically with tyrosine kinase inhibitors (TKIs), potentially ...